Saltar al contenido principal
Elsevier

Nanotechnology Based Approaches for Tuberculosis Treatment

  • 1 Edición - 10 de junio de 2020
  • Última edición
  • Editor: Prashant Kesharwani
  • Idioma: Inglés

Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventio… Leer más

Descripción

Nanotechnology Based Approaches for Tuberculosis Treatment discusses multiple nanotechnology-based approaches that may help overcome persisting limitations of conventional and traditional treatments. The book summarizes the types of nano drugs, their synthesis, formulation, characterization and applications, along with the most important administration routes. It also explores recent advances and achievements regarding therapeutic efficacy and provides possible future applications in this field. It will be a useful resource for investigators, pharmaceutical researchers, innovators and scientists working on technology advancements in the areas of targeted therapies, nano scale imaging systems, and diagnostic modalities in tuberculosis.

Puntos claves

  • Addresses the gap between nanomedicine late discovery and early development of tuberculosis therapeutics
  • Explores tuberculosis nanomedicine standardization and characterization with newly developed treatment, diagnostic and treatment monitoring modalities
  • Covers the field thoroughly, from the pathogenesis of tuberculosis and multi-drug resistant mycobacterium tuberculosis, to treatment approaches using nanotechnology and different nanocarriers

De interès para

Researchers, early-career investigators, and graduate students working in the pharmaceutical industries, nanomedicine, or infectious diseases

Índice

1. Pathogenesis, biology, and immunology of tuberculosisRAVI BANDARU, DEVIPRASAD SAHOO, RAMAKANTA NAIK, PRASHANT KESHARWANI AND RAMBABU DANDELA2. Tuberculosis: introduction, drug regimens, and multidrug-resistanceSIMA SINGH, NEELAM DHANKAR, ASHISH KUMAR GARG AND PRASHANT KESHARWANI3. Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis DAMIÁN EDUARDO PÉREZ-MARTÍNEZ AND ROBERTO ZENTENO-CUEVAS4. Translational research for therapy against tuberculosis YOLANDA GONZALEZ, SILVIA GUZMÁN-BELTRÁN, LAURA E. CARRETO-BINAGHI AND ESMERALDA JUÁREZ5. Vaccine delivery systems against tuberculosis RUPAL OJHA, RAJAN KUMAR PANDEY AND VIJAY KUMAR PRAJAPATI6. Inhalable polymeric dry powders for antituberculosis drug delivery SUNEERA ADLAKHA, KALPESH VAGHASIYA, ANKUR SHARMA, EUPA RAY AND RAHUL KUMAR VERMA7. Liposomes-and niosomes-based drug delivery systems for tuberculosis treatmentALI IBRAHIM BEKRAKI8. Polymer-based nanoparticles as delivery systems for treatment and vaccination of tuberculosis MOHSEN TAFAGHODI, FARZAD KHADEMI, FARIDEH SHIEHZADEH AND ZOHREH FIROZI9. Nanotechnology-based approaches for tuberculosis treatmentMOHAMAD MOSA MUBARAK AND ZAHOOR AHMAD10. Dendrimer-based drug delivery systems for tuberculosis treatmentRAHUL SHUKLA, AAKRITI SETHI, MAYANK HANDA, MRADUL MOHAN, PRASHANT KESHARWANI AND PUSHPENDRA K. TRIPATHI11. Polymeric micelle-based drug delivery systems for tuberculosis treatmentBAPI GORAIN, HIRA CHOUDHURY, SREENIVAS PATRO AND PRASHANT KESHARWANI12. Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatmentSIMONE PINTO CARNEIRO AND ORLANDO DAVID HENRIQUE DOS SANTOS13. DNA markers and nano-biosensing approaches for tuberculosis diagnosisAMAL RABTI, AMAL RAOUAFI AND NOUREDDINE RAOUAFI14. Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis Noorsuzana Mohd Shariff15. Nanotechnology approach in conquering anti-TB resistanceB.D. NOVITA

Detalles del producto

  • Edición: 1
  • Última edición
  • Publicado: 10 de junio de 2020
  • Idioma: Inglés

Sobre el editor

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience across various countries. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has published many articles in well-reputed journals and a large number of books. He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, and “SERB-Ramanujan Fellowship Award”. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

Afiliaciones y experiencia
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India

Ver libro en ScienceDirect

Lee Nanotechnology Based Approaches for Tuberculosis Treatment en ScienceDirect